United States Cuffless Blood Pressure Monitoring Devices Market to hit US$ 519.45 Million by 2033 | Major Companies 2026 - Biobeat Technologies, Omron, CardiacSense

Leander, Texas and Tokyo, Japan - Jan.13.2026
As per DataM intelligence research report "The Global Cuffless Blood Pressure Monitoring Devices Market reached US$681.17 million in 2024 and is expected to reach US$ 1731.5 million by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033"

The cuffless blood pressure monitoring devices market is rapidly growing as wearable and non-invasive health tech gains traction. AI-driven sensors, wireless connectivity, and advanced biometric algorithms enhance accuracy and patient convenience. Rising prevalence of cardiovascular diseases and remote monitoring demand are driving sustained market growth.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/cuffless-blood-pressure-monitoring-devices-market?prasad

Cuffless Blood Pressure Monitoring Devices Market: Competitive Intelligence
Biobeat Technologies, Omron, CardiacSense, Valencell, Inc, Aktiia SA, Equate Health, Healthstats International Pte. Ltd., Corsano Health, SOMNOmedics AG, LiveMetric and among others.

In the Cuffless Blood Pressure Monitoring Devices Market, the combined influence of Biobeat Technologies, Omron, CardiacSense, Valencell, Inc., Aktiia SA, Equate Health, Healthstats International Pte. Ltd., and Corsano Health is advancing the industry toward more accessible, continuous, and user‐centric cardiovascular monitoring. These companies bring clinically validated technologies and sensor innovations that address limitations of traditional cuff‐based measurement, helping clinicians and consumers alike capture blood pressure trends with greater comfort and convenience. Their work supports broader adoption of wearable and mobile health solutions that align with preventive care models and remote patient monitoring programs, enhancing early detection and risk management for hypertension and related conditions. Through global distribution and regulatory engagement, they contribute to increased market penetration and standardized approaches to cuffless blood pressure assessment. The collective momentum they generate strengthens the Cuffless Blood Pressure Monitoring Devices Market's credibility and relevance in the evolving digital health ecosystem.

Individually and in combination, these firms' complementary strengths fuel competitive differentiation across the Cuffless Blood Pressure Monitoring Devices Market by blending sensor accuracy, regulatory rigor, and user experience optimization. Biobeat Technologies and CardiacSense focus on medical‐grade physiological monitoring, enabling integration with clinical workflows and telehealth platforms that support care continuity. Omron's deep legacy in cardiovascular devices and broad healthcare network enhances trust and accessibility for cuffless innovations, reinforcing adoption across diverse patient populations. Valencell, Inc. and Aktiia SA bring advanced biometric sensor platforms and patented signal‐processing algorithms that improve measurement stability in wearable formats, while Equate Health and Healthstats International Pte. Ltd. emphasize scalable solutions for population health insights and long‐term trend analysis. Corsano Health's focus on comprehensive wearable diagnostics further deepens the market's ability to support multifactor health tracking, creating a synergistic environment where device performance, data integration, and user engagement coalesce.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cuffless-blood-pressure-monitoring-devices-market?prasad

United States: Recent Industry Developments

✅ In January 2026, Omron Healthcare launched AI-enabled cuffless blood pressure monitors with automated data integration into health apps, enabling continuous monitoring, telehealth integration, and reducing manual measurements while improving patient data accuracy.

✅ In November 2025, iRhythm Technologies invested $50 million in developing automated wearable solutions that track cardiovascular metrics including cuffless blood pressure, integrating AI alerts and cloud-based patient data management to improve care delivery.

✅ In August 2025, hospitals implemented automated AI-based monitoring systems integrating cuffless BP devices to reduce manual measurement errors, enable remote patient tracking, and streamline workflow efficiency across multiple wards.

✅ In June 2025, startups introduced portable cuffless devices capable of continuous automated blood pressure tracking, providing real-time data analytics, automated alerts, and integration with electronic health records for clinical research and patient care.

Japan: Recent Industry Developments

✅ In January 2026, Omron Japan deployed AI-assisted cuffless BP monitors in elderly care facilities, backed by $20 million investment, improving remote patient monitoring, workflow efficiency, and data accuracy while reducing manual measurement burdens on staff.

✅ In October 2025, Fujitsu developed wearable cuffless BP sensors integrated into automated patient management systems, enabling real-time monitoring, AI-driven trend analysis, and early detection of anomalies for better healthcare outcomes.

✅ In July 2025, NEC piloted automated health monitoring kiosks using cuffless devices in hospitals, allowing continuous BP measurement, automated data logging, and workflow optimization to reduce staff workload and improve patient safety.

✅ In April 2025, Japanese universities tested AI-enhanced cuffless BP systems in telemedicine programs, integrating automated alerts, data analytics, and remote monitoring capabilities for improved clinical decision-making and patient care.

Segment Covered in the Cuffless Blood Pressure Monitoring Devices Market:
By Product Type
The market is segmented into wearable devices 55%, handheld/portable devices 25%, and continuous monitoring devices 20%. Wearable devices dominate due to growing adoption of smartwatches and fitness bands with integrated blood pressure monitoring features. Handheld devices are used in home-care and outpatient settings, while continuous monitoring devices are gaining traction in clinical and remote patient monitoring applications.

By Technology
Technologies include photoplethysmography (PPG) 40%, pulse transit time (PTT) 35%, tonometry 15%, and others 10%. PPG-based technology dominates due to its non-invasive nature and easy integration into wearables. PTT technology is expanding with advancements in sensor accuracy and AI-based algorithms. Tonometry and other technologies are primarily used in specialized medical and research applications.

By Application
Applications include hypertension management 45%, fitness & wellness monitoring 30%, cardiac health monitoring 15%, and others 10%. Hypertension management leads due to the rising global prevalence of high blood pressure and demand for continuous, non-invasive monitoring. Fitness and wellness applications are growing rapidly with consumer health awareness and preventive healthcare trends.

By End User
End-users include home care settings 40%, hospitals 30%, ambulatory care centers 20%, and others 10%. Home care dominates due to increasing preference for remote monitoring, aging populations, and chronic disease management. Hospitals and ambulatory centers adopt cuffless devices for continuous monitoring and early diagnosis.

Regional Analysis
North America - 35% Share
North America leads with 35% share driven by advanced healthcare infrastructure, high adoption of wearable health technologies, and strong presence of digital health companies in the U.S. and Canada.

Europe - 25% Share
Europe accounts for 25% share supported by rising preventive healthcare initiatives, aging population, and adoption of remote patient monitoring technologies in Germany, the U.K., and France.

Asia Pacific - 25% Share
Asia Pacific holds 25% share due to increasing smartphone and wearable penetration, growing healthcare expenditure, and large hypertensive population in China, India, Japan, and South Korea.

Latin America - 8% Share
Latin America represents 8% share with growing adoption of digital health solutions and expanding access to home healthcare devices in Brazil and Mexico.

Middle East & Africa - 7% Share
Middle East & Africa accounts for 7% share driven by increasing healthcare digitization, rising awareness of cardiovascular diseases, and investments in smart healthcare technologies.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=cuffless-blood-pressure-monitoring-devices-market

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.